SGIP1 binding to the α-helicalH9domain of cannabinoid receptor 1 promotes axonal surface expression
preprint
OA: gold
CC-BY-4.0
Abstract
Endocannabinoid signalling mediated by cannabinoid type 1 receptors (CB1Rs) is critical for homeostatic neuromodulation of both excitatory and inhibitory synapses. This requires highly polarised axonal surface expression of CB1R, but how this is achieved remains unclear. We previously reported that the H9 domain in the intracellular C-terminus of CB1R contributes to polarised surface expression by an unknown mechanism. Here we show the H9 domain binds to the endocytic adaptor protein SGIP1 to promote CB1R expression in the axonal membrane. Overexpression of SGIP1 increases CB1R axonal surface localisation but has no effect on CB1R lacking the H9 domain (CB1R ΔH9 ). Conversely, SGIP1 knockdown reduces axonal surface expression of CB1R but does not affect CB1R ΔH9 . Furthermore, SGIP1 knockdown diminishes CB1R-mediated inhibition of presynaptic Ca 2+ influx in response to neuronal activity. Together, these data advance mechanistic understanding of endocannabinoid signalling by demonstrating that SGIP1 interaction with H9 underpins axonal CB1R surface expression to regulate presynaptic responsiveness.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (43)
- doi:10.1016/j.neuron.2012.09.020 via crossref
- doi:10.1038/nm.f.1869 via crossref
- doi:10.3389/fnint.2018.00051 via crossref
- doi:10.1038/npp.2017.206 via crossref
- doi:10.1016/s0306-4522(00)00120-2 via crossref
- doi:10.1523/jneurosci.21-07-02425.2001 via crossref
- doi:10.1523/jneurosci.5437-05.2006 via crossref
- doi:10.1124/mol.106.029348 via crossref
- doi:10.1096/fj.07-102731 via crossref
- doi:10.1093/cercor/bhs240 via crossref
- doi:10.1093/jmcb/mjt014 via crossref
- doi:10.3389/fnmol.2018.00230 via crossref
- doi:10.7554/elife.44252 via crossref
- doi:10.1242/dev.184069 via crossref
- doi:10.1523/jneurosci.19-11-04544.1999 via crossref
- doi:10.1016/j.neuroscience.2005.01.026 via crossref
- doi:10.1038/nn.3892 via crossref
- doi:10.1073/pnas.89.9.3825 via crossref
- doi:10.1016/j.neuron.2007.05.020 via crossref
- doi:10.3389/fnmol.2020.00108 via crossref
- doi:10.1210/en.2005-0282 via crossref
- doi:10.1126/science.1252884 via crossref
- doi:10.1016/j.neuropharm.2016.03.008 via crossref
- doi:10.1186/s13041-019-0464-1 via crossref
- doi:10.1074/jbc.m703815200 via crossref
- doi:10.1371/journal.pone.0021678 via crossref
- doi:10.1091/mbc.e09-05-0429 via crossref
- doi:10.1016/j.bbrc.2010.10.045 via crossref
- doi:10.1016/j.bbrc.2018.09.075 via crossref
- doi:10.1038/s41598-021-87591-3 via crossref
- doi:10.3389/fcell.2021.801420 via crossref
- doi:10.1111/jnc.15569 via crossref
- doi:10.1111/bph.15383 via crossref
- doi:10.1016/j.mcn.2007.02.016 via crossref
- doi:10.1371/journal.pone.0205781 via crossref
- doi:10.1016/j.celrep.2013.10.039 via crossref
- doi:10.1152/jn.1997.78.1.43 via crossref
- doi:10.1038/nature05453 via crossref
- doi:10.7554/elife.03648 via crossref
- doi:10.1016/j.xpro.2021.100992 via crossref
- doi:10.1007/978-1-0716-2569-9_1 via crossref
- doi:10.1371/journal.pone.0050850 via crossref
- doi:10.1016/j.neuron.2014.02.018 via crossref
Source provenance
- crossref
- last seen: 2026-05-28T01:00:26.338100+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-4.0